Biodesix Inc
NASDAQ:BDSX

Watchlist Manager
Biodesix Inc Logo
Biodesix Inc
NASDAQ:BDSX
Watchlist
Price: 1.28 USD 6.67% Market Closed
Market Cap: 186.2m USD
Have any thoughts about
Biodesix Inc?
Write Note

Intrinsic Value

BDSX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one BDSX stock under the Base Case scenario is 1.93 USD. Compared to the current market price of 1.28 USD, Biodesix Inc is Undervalued by 34%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BDSX Intrinsic Value
1.93 USD
Undervaluation 34%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Biodesix Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BDSX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BDSX?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Biodesix Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Biodesix Inc

Provide an overview of the primary business activities
of Biodesix Inc.

What unique competitive advantages
does Biodesix Inc hold over its rivals?

What risks and challenges
does Biodesix Inc face in the near future?

Has there been any significant insider trading activity
in Biodesix Inc recently?

Summarize the latest earnings call
of Biodesix Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biodesix Inc.

Provide P/S
for Biodesix Inc.

Provide P/E
for Biodesix Inc.

Provide P/OCF
for Biodesix Inc.

Provide P/FCFE
for Biodesix Inc.

Provide P/B
for Biodesix Inc.

Provide EV/S
for Biodesix Inc.

Provide EV/GP
for Biodesix Inc.

Provide EV/EBITDA
for Biodesix Inc.

Provide EV/EBIT
for Biodesix Inc.

Provide EV/OCF
for Biodesix Inc.

Provide EV/FCFF
for Biodesix Inc.

Provide EV/IC
for Biodesix Inc.

Show me price targets
for Biodesix Inc made by professional analysts.

What are the Revenue projections
for Biodesix Inc?

How accurate were the past Revenue estimates
for Biodesix Inc?

What are the Net Income projections
for Biodesix Inc?

How accurate were the past Net Income estimates
for Biodesix Inc?

What are the EPS projections
for Biodesix Inc?

How accurate were the past EPS estimates
for Biodesix Inc?

What are the EBIT projections
for Biodesix Inc?

How accurate were the past EBIT estimates
for Biodesix Inc?

Compare the revenue forecasts
for Biodesix Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biodesix Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biodesix Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biodesix Inc compared to its peers.

Compare the P/E ratios
of Biodesix Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Biodesix Inc with its peers.

Analyze the financial leverage
of Biodesix Inc compared to its main competitors.

Show all profitability ratios
for Biodesix Inc.

Provide ROE
for Biodesix Inc.

Provide ROA
for Biodesix Inc.

Provide ROIC
for Biodesix Inc.

Provide ROCE
for Biodesix Inc.

Provide Gross Margin
for Biodesix Inc.

Provide Operating Margin
for Biodesix Inc.

Provide Net Margin
for Biodesix Inc.

Provide FCF Margin
for Biodesix Inc.

Show all solvency ratios
for Biodesix Inc.

Provide D/E Ratio
for Biodesix Inc.

Provide D/A Ratio
for Biodesix Inc.

Provide Interest Coverage Ratio
for Biodesix Inc.

Provide Altman Z-Score Ratio
for Biodesix Inc.

Provide Quick Ratio
for Biodesix Inc.

Provide Current Ratio
for Biodesix Inc.

Provide Cash Ratio
for Biodesix Inc.

What is the historical Revenue growth
over the last 5 years for Biodesix Inc?

What is the historical Net Income growth
over the last 5 years for Biodesix Inc?

What is the current Free Cash Flow
of Biodesix Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biodesix Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biodesix Inc

Current Assets 44m
Cash & Short-Term Investments 31.4m
Receivables 8m
Other Current Assets 4.6m
Non-Current Assets 58.7m
PP&E 30.6m
Intangibles 21.5m
Other Non-Current Assets 6.7m
Current Liabilities 13m
Accounts Payable 2.5m
Accrued Liabilities 6.5m
Other Current Liabilities 3.9m
Non-Current Liabilities 61.9m
Long-Term Debt 36.1m
Other Non-Current Liabilities 25.8m
Efficiency

Earnings Waterfall
Biodesix Inc

Revenue
65.6m USD
Cost of Revenue
-14.6m USD
Gross Profit
51m USD
Operating Expenses
-85.5m USD
Operating Income
-34.6m USD
Other Expenses
-9.3m USD
Net Income
-43.8m USD

Free Cash Flow Analysis
Biodesix Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BDSX Profitability Score
Profitability Due Diligence

Biodesix Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
ROIC is Increasing
Exceptional 1-Year Revenue Growth
26/100
Profitability
Score

Biodesix Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

BDSX Solvency Score
Solvency Due Diligence

Biodesix Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
Average D/E
35/100
Solvency
Score

Biodesix Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BDSX Price Targets Summary
Biodesix Inc

Wall Street analysts forecast BDSX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BDSX is 3.16 USD with a low forecast of 3.03 USD and a high forecast of 3.68 USD.

Lowest
Price Target
3.03 USD
137% Upside
Average
Price Target
3.16 USD
147% Upside
Highest
Price Target
3.68 USD
187% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BDSX?

Click here to dive deeper.

Dividends

Biodesix Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BDSX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BDSX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Biodesix Inc Logo
Biodesix Inc

Country

United States of America

Industry

Health Care

Market Cap

186.2m USD

Dividend Yield

0%

Description

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The company is headquartered in Boulder, Colorado and currently employs 218 full-time employees. The company went IPO on 2020-10-28. The firm uses its artificial intelligence (AI) platform, Diagnostic Cortex, to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus on lung disease. In addition to its diagnostic tests, it provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development and commercialization of companion diagnostics. The firm offers blood-based lung cancer tests across the lung cancer continuum of care, including Nodify XL2 and Nodify CDT tests, and GeneStrat and VeriStrat tests. The firm also offers three SARS-CoV-2 tests under the Biodesix WorkSafe testing program, such as Bio-Rad SARS-CoV-2 ddPCR test, Platelia SARS-CoV-2 Total Ab test and cPass SARS-CoV-2 Neutralization Antibody Test.

Contact

COLORADO
Boulder
2970 Wilderness Place, Suite 100
+13034170500.0
www.biodesix.com

IPO

2020-10-28

Employees

218

Officers

President, CEO & Director
Mr. Scott Hutton
CFO, Secretary & Treasurer
Ms. Robin Harper Cowie
Chief Commercial Officer
Mr. Kieran O'Kane
Founder & CTO
Dr. Heinrich Röder
Senior Director of Human Resources
Ms. Jessica Olbricht
Chief Development Officer
Dr. Gary Anthony Pestano Ph.D.
Show More
Chief Growth Officer
Ms. Bobbi Coffin
Co-Chief Medical Officer
Dr. Steven C. Springmeyer
VP & Controller
Mr. Christopher Vazquez
Show Less

See Also

Discover More
What is the Intrinsic Value of one BDSX stock?

The intrinsic value of one BDSX stock under the Base Case scenario is 1.93 USD.

Is BDSX stock undervalued or overvalued?

Compared to the current market price of 1.28 USD, Biodesix Inc is Undervalued by 34%.

Back to Top